Best Biotechnology Stocks

Biotech stocks open the door to investing in innovation that’s shaping the future of healthcare. From pioneering drug developers to specialized firms in genetic engineering and diagnostics, this sector offers exposure to breakthroughs with the potential for transformative impact—and strong returns. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

The list below highlights some of the most widely followed biotech stocks in today’s market. It features a range of companies—from established leaders with approved therapies to up-and-coming firms advancing promising clinical pipelines. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

On This Page: Biotech Stock Resources FAQ Why Invest in Biotech Stocks

Company	Current Price	P/E Ratio	Market Cap	Volume	Average Volume	Indicator(s)
ABBV AbbVie	$233.42 +1.4%	111.15	$406.64 billion	4.90 million	6.64 million	Trending News
TMO Thermo Fisher Scientific	$539.54 -0.8%	31.21	$205.40 billion	1.87 million	2.64 million	Positive News Analyst Forecast
DHR Danaher	$208.63 -1.5%	44.39	$151.60 billion	4.01 million	5.12 million	Positive News Analyst Forecast
VRTX Vertex Pharmaceuticals	$410.28 +1.8%	29.33	$103.30 billion	1.59 million	1.74 million	Positive News
GSK GSK	$43.52 +0.1%	20.15	$88.40 billion	3.87 million	6.03 million	Dividend Cut
ALNY Alnylam Pharmaceuticals	$459.58 +1.7%	N/A	$59.25 billion	791,843	1.18 million	Analyst Forecast
COR Cencora	$308.63 +1.1%	31.75	$59.19 billion	875,928	1.75 million	Trending News Analyst Revision
VEEV Veeva Systems	$306.45 +2.2%	62.93	$49.13 billion	1.86 million	1.27 million	Positive News Analyst Upgrade Gap Up
ARGX argenex	$797.35 +1.2%	40.89	$48.22 billion	221,774	360,523	Positive News
TAK Takeda Pharmaceutical	$14.47 -0.6%	48.22	$46.30 billion	2.81 million	2.63 million
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
IQV IQVIA	$200.66 -2.1%	29.04	$34.85 billion	1.18 million	1.32 million	Positive News
CTSH Cognizant Technology Solutions	$67.94 +0.2%	13.81	$33.11 billion	4.35 million	4.57 million	Positive News
BNTX BioNTech	$106.06 +0.9%	N/A	$25.28 billion	704,314	1.11 million
RPRX Royalty Pharma	$36.10 -0.1%	20.87	$21.07 billion	2.07 million	5.38 million
UTHR United Therapeutics	$456.84 +0.8%	17.83	$20.45 billion	610,683	858,493	Insider Trade
BE Bloom Energy	$86.00 -1.1%	2,150.51	$20.35 billion	10.80 million	16.13 million	Analyst Forecast Gap Up
IFF International Flavors & Fragrances	$61.05 -0.7%	N/A	$15.76 billion	2.99 million	2.35 million	Trending News Analyst Forecast
ILMN Illumina	$96.68 -4.3%	12.24	$15.53 billion	1.39 million	1.69 million	Analyst Forecast
ICLR Icon	$186.65 -2.0%	19.20	$15.38 billion	640,405	1.07 million
MEDP Medpace	$531.85 +0.3%	39.54	$14.90 billion	229,171	318,873	Positive News
FN Fabrinet	$370.54 +0.1%	40.36	$13.23 billion	378,684	555,222	Positive News
SUZ Suzano	$9.16 -2.2%	8.10	$12.39 billion	2.41 million	1.40 million
LITE Lumentum	$157.15 -2.1%	683.26	$11.23 billion	2.52 million	3.49 million
RVTY Revvity	$91.20 -2.3%	38.65	$10.84 billion	1.30 million	1.25 million	Analyst Forecast
MRNA Moderna	$27.34 -0.7%	N/A	$10.76 billion	6.06 million	12.29 million
CRL Charles River Laboratories International	$170.12 -2.8%	N/A	$8.61 billion	879,420	1.01 million	Analyst Upgrade
BIO.B Bio-Rad Laboratories	$284.88	24.29	$7.75 billion	22	53	Negative News
ABVX Abivax	$87.01 +0.4%	N/A	$6.55 billion	728,778	1.01 million	Analyst Forecast
IBB iShares Biotechnology ETF	$150.48 0.0%	N/A	$6.19 billion	1.96 million	2.16 million	News Coverage
TGTX TG Therapeutics	$36.50 -0.7%	98.65	$5.83 billion	1.53 million	1.91 million	Analyst Forecast Analyst Revision
LEGN Legend Biotech	$31.41 -0.1%	N/A	$5.80 billion	836,404	1.29 million	News Coverage Positive News Analyst Forecast
PCVX Vaxcyte	$41.87 +1.6%	N/A	$5.35 billion	1.92 million	2.07 million
KRYS Krystal Biotech	$183.02 +1.4%	37.20	$5.23 billion	210,406	384,249	Positive News
MENS Jyong Biotech	$55.11 +6.0%	N/A	$3.95 billion	297,564	373,048
AAPG Ascentage Pharma Group International	$38.88 -2.5%	N/A	$3.71 billion	5,664	8,192	News Coverage
ODD ODDITY Tech	$59.40 -0.5%	33.00	$3.33 billion	293,469	410,253
HTGC Hercules Capital	$17.90 -2.2%	11.85	$3.32 billion	1.85 million	925,189	High Trading Volume
TPC Tutor Perini	$61.49 -2.1%	N/A	$3.31 billion	447,745	539,525	Positive News
JTEK JPMorgan U.S. Tech Leaders ETF	$92.80 -1.2%	47.07	$2.75 billion	251,642	242,167
BEAM Beam Therapeutics	$25.13 -2.9%	N/A	$2.62 billion	1.43 million	2.42 million

SXI Standex International	$213.98 -1.0%	46.12	$2.61 billion	151,162	99,910
FOLD Amicus Therapeutics	$8.16	N/A	$2.52 billion	3.32 million	5.84 million
CDTX Cidara Therapeutics	$102.17 +5.9%	N/A	$2.45 billion	1.28 million	1.20 million
RXRX Recursion Pharmaceuticals	$5.23 -5.4%	N/A	$2.40 billion	33.95 million	34.13 million
IBRX ImmunityBio	$2.50 -1.2%	N/A	$2.39 billion	9.58 million	10.92 million
DNLI Denali Therapeutics	$14.90 -2.1%	N/A	$2.23 billion	1.28 million	2.12 million
ADPT Adaptive Biotechnologies	$14.35 -0.8%	N/A	$2.20 billion	1.78 million	2.09 million
CELC Celcuity	$49.22 +2.9%	N/A	$2.03 billion	898,581	998,497
VERA Vera Therapeutics	$30.80 -0.5%	N/A	$1.97 billion	925,773	1.56 million	Positive News
TWST Twist Bioscience	$31.12 -2.3%	N/A	$1.92 billion	2.90 million	1.75 million	Analyst Forecast
APGE Apogee Therapeutics	$39.73 -0.2%	N/A	$1.84 billion	495,172	553,304
COGT Cogent Biosciences	$15.44 -2.9%	N/A	$1.81 billion	1.63 million	2.17 million
DYN Dyne Therapeutics	$13.95 +10.3%	N/A	$1.80 billion	3.15 million	2.43 million
IMCR Immunocore	$34.22 +0.6%	N/A	$1.71 billion	282,325	290,993	Positive News
VRDN Viridian Therapeutics	$21.00 +0.8%	N/A	$1.70 billion	564,732	678,034	Positive News
RDW Redwire	$11.02 -1.8%	N/A	$1.62 billion	9.52 million	7.87 million
TXG 10x Genomics	$11.60 -8.2%	N/A	$1.57 billion	2.87 million	2.70 million	Positive News
NVAX Novavax	$9.22 +1.5%	4.04	$1.47 billion	4.21 million	4.49 million
BCRX BioCryst Pharmaceuticals	$6.95 -1.0%	N/A	$1.47 billion	3.96 million	2.94 million
AZTA Azenta	$30.73 -3.4%	N/A	$1.46 billion	315,235	660,209
EVO Evotec	$3.92 -1.8%	N/A	$1.42 billion	22,571	45,666
PHR Phreesia	$23.41 -0.3%	N/A	$1.41 billion	755,317	989,288
IMNM Immunome	$13.82 -4.1%	N/A	$1.25 billion	1.30 million	2.00 million
ZYME Zymeworks	$16.50 -1.1%	N/A	$1.25 billion	828,690	625,870
ZYME Zymeworks	$16.50 -1.1%	N/A	$1.24 billion	828,690	540,332	Positive News
TRML Tourmaline Bio	$47.89 +0.0%	N/A	$1.23 billion	395,665	2.08 million	Short Interest ↓
WVE WAVE Life Sciences	$7.19 -0.4%	N/A	$1.15 billion	897,912	1.82 million	News Coverage
AMLX Amylyx Pharmaceuticals	$13.49 +6.3%	N/A	$1.13 billion	1.83 million	2.25 million
OCSL Oaktree Specialty Lending	$12.59 -1.6%	22.48	$1.13 billion	927,747	866,542
DNTH Dianthus Therapeutics	$34.70 +0.7%	N/A	$1.11 billion	326,063	947,123
NBTX Nanobiotix	$20.97 -7.9%	N/A	$1.09 billion	121,069	113,546	Analyst Revision Gap Down
DHC Diversified Healthcare Trust	$4.33 +0.2%	N/A	$1.04 billion	611,537	962,072
UPB Upstream Bio	$18.67 -1.6%	N/A	$1.02 billion	190,145	462,482
RAPP Rapport Therapeutics	$26.44 -4.7%	N/A	$1.01 billion	332,942	1.16 million
SYRE Spyre Therapeutics	$16.02 -3.9%	N/A	$1.01 billion	439,743	681,165	Analyst Downgrade
HQH abrdn Healthcare Investors	$18.54 +0.9%	N/A	$989.45 million	178,073	189,262
SANA Sana Biotechnology	$4.12 -1.0%	N/A	$989.28 million	4.11 million	3.72 million	Positive News
SEPN Septerna	$21.01 +1.0%	N/A	$927.37 million	449,906	282,968
THR Thermon Group	$26.42 -3.8%	16.72	$908.30 million	295,573	247,974	Positive News
DNA Ginkgo Bioworks	$14.81 -0.4%	N/A	$880.30 million	1.65 million	1.69 million
FTRE Fortrea	$9.31 -2.9%	N/A	$870.77 million	940,619	1.51 million	Analyst Forecast
PROK ProKidney	$2.96 +2.1%	N/A	$853.42 million	3.49 million	2.39 million
ANAB AnaptysBio	$29.87 -1.3%	N/A	$846.91 million	224,800	753,022	Gap Up
TNGX Tango Therapeutics	$7.29 -3.8%	N/A	$843.35 million	2.13 million	2.59 million
PRME Prime Medicine	$5.87 -3.5%	N/A	$818.21 million	5.59 million	3.84 million
IOVA Iovance Biotherapeutics	$2.18 -1.4%	N/A	$799.70 million	11.89 million	9.83 million
PRME Prime Medicine	$5.87 -3.5%	N/A	$789.95 million	5.59 million	2.69 million	High Trading Volume
URGN Urogen Pharma	$16.84 -1.2%	N/A	$788.80 million	841,719	1.22 million
VIR Vir Biotechnology	$5.66 +1.3%	N/A	$776.54 million	875,856	1.15 million	News Coverage Insider Trade
ORKA Oruka Therapeutics	$20.57 +1.2%	N/A	$761.37 million	404,819	511,159

TYRA Tyra Biosciences	$13.37 -0.4%	N/A	$715.78 million	114,110	188,793
ARVN Arvinas	$9.30 -3.3%	N/A	$706.28 million	2.32 million	2.27 million	Analyst Forecast
TRNS Transcat	$70.64 -0.3%	49.40	$659.98 million	73,663	89,502
RGNX REGENXBIO	$10.51 -1.7%	N/A	$540 million	513,342	513,141	News Coverage Analyst Forecast
PRTA Prothena	$10.17 +3.1%	N/A	$530.76 million	1.03 million	741,614	News Coverage Analyst Forecast Gap Up
RIGL Rigel Pharmaceuticals	$29.50 +2.1%	5.45	$518.39 million	679,222	675,951
LAB Standard BioTools	$1.30 -1.5%	N/A	$504.23 million	1.46 million	1.19 million
TCPC Blackrock Tcp Capital	$5.84 -1.2%	N/A	$502.57 million	750,255	850,289
GLUE Monte Rosa Therapeutics	$7.38 -3.7%	20.50	$473.08 million	697,682	2.53 million	Positive News
PRTC PureTech Health	$18.61 -2.0%	N/A	$458.72 million	439	5,328

Resources

Biotech Stocks Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.

Top Biotech Stocks: Exploring Innovation Opportunities

Written by Jessica Mitacek | Reviewed by Don Miller

Updated June 6, 2024 | Reviewed on June 6, 2024

Biotech stocks continue to be a robust sector of the stock market. An aging population with increasing healthcare demands, combined with rapidly growing and improving technology, supports the growth of biotech stocks. The biotech industry is highly competitive and incredibly diverse, with a few companies managing to stand out and make a name for themselves.

Biotech stocks can be highly volatile, and some investors choose to diversify their exposure through biotech-focused exchange traded funds (ETFs) or mutual funds to mitigate some of the risks while allowing investors to benefit from the sector's overall growth. Some top ETFs tracking companies in the biotech sector are the SPDR S&P Biotech ETF (NYSEARCA: XBI), iShares Biotechnology ETF (NASDAQ : IBB), and ALPS Medical Breakthroughs ETF (NYSEARCA: SBIO).

Let’s take a look at some of the top biotech companies in the world.

Vertex Pharmaceuticals (NASDAQ: VRTX)

Vertex focuses on treatments for cystic fibrosis and has seen strong growth in recent years. The company ranks highly among biotech companies and is exploring gene editing as a treatment for muscular dystrophy and sickle cell anemia. Vertex’s rapid profit growth makes it an attractive investment.

Regeneron Pharmaceuticals (NASDAQ: REGN)

Regeneron has a robust pipeline of drugs, including successful treatments like EYLEA for eye diseases and Dupixent for autoimmune diseases, as well as promising candidates like odronextamab for follicular lymphoma. The company invests heavily in R&D, leading to breakthroughs in treatments for serious conditions, positioning it as a leader in the biotech industry.

Moderna (NASDAQ: MRNA)

Known for its COVID-19 vaccine, Moderna is developing new vaccines and treatments including a flu/COVID-19 combination vaccine expected by 2025 and an RSV vaccine candidate that could be approved soon. The company is investing heavily in mRNA technology for other vaccines and treatments.

Amgen (NASDAQ: AMGN)

As one of the largest biotech companies, Amgen has a diverse portfolio of drugs for various conditions. The company is valued at over $100 billion and offers a generous dividend yield, making it a stable investment.

BioMarin Pharmaceutical (NASDAQ: BMRN)

BioMarin focuses on rare diseases and gene therapies. Its significant products include Vimizim, Voxzogo, and Roctavian, which have shown substantial sales growth.

Gilead Sciences (NASDAQ: GILD)

A leader in both HIV and liver diseases, Gildead is known for its revolutionary treatment for Hepatitis C released in 2014. The company has a strong pipeline with promising therapies in development, particularly in oncology and virology, which are expected to drive future growth. Gilead has also made strategic acquisitions to bolster its R&D capabilities and expand its market presence.

Legend Biotech (NASDAQ: LEGN)

This clinical-stage biopharma company specializes in cell therapies for cancer. Its breakthrough CAR-T cell therapy, Carvykti, has shown significant efficacy in treating multiple myeloma. In addition, the company has collaborated with Johnson & Johnson’s Janssen unit.

About The Editor

Jessica Mitacek

Associate Editor & Contributing Author

Market Analysis and Research

Learn More

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Best Biotechnology Stocks

Resources

Biotech Stocks Frequently Asked Questions

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Best Biotechnology Stocks

Resources

Biotech Stocks Frequently Asked Questions

What Are Biotech Stocks?

What Are the Leading Companies in the Biotech Sector?

How Can I Invest in Biotech Stocks?

What Should I Consider Before Investing in Biotech Stocks?

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools